Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice.
about
Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosisRole of Nucleotide-binding and Oligomerization Domain 2 Protein (NOD2) in the Development of AtherosclerosisAnti-inflammatory therapy in chronic disease: challenges and opportunitiesNoncoding RNAs regulate NF-κB signaling to modulate blood vessel inflammationIKKε knockout prevents high fat diet induced arterial atherosclerosis and NF-κB signaling in miceBone marrow p16INK4a-deficiency does not modulate obesity, glucose homeostasis or atherosclerosis developmentMacrophages in the pathogenesis of atherosclerosisNovel functions of PXR in cardiometabolic disease.Recent insights into the cellular biology of atherosclerosisEchogenic perfluorohexane-loaded macrophages adhere in vivo to activated vascular endothelium in mice, an explorative study.Inactivation of the adenosine A2A receptor protects apolipoprotein E-deficient mice from atherosclerosisPlatelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis.Data on gene and protein expression changes induced by apabetalone (RVX-208) in ex vivo treated human whole blood and primary hepatocytes.IKKβ links vascular inflammation to obesity and atherosclerosisInhibition of protein kinase C-driven nuclear factor-kappaB activation: synthesis, structure-activity relationship, and pharmacological profiling of pathway specific benzimidazole probe molecules.Homeobox transcription factor VentX regulates differentiation and maturation of human dendritic cells.Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profileSystemic delivery of microRNA-181b inhibits nuclear factor-κB activation, vascular inflammation, and atherosclerosis in apolipoprotein E-deficient mice.Mechanisms that regulate macrophage burden in atherosclerosis.Hepatocyte-specific IKKβ expression aggravates atherosclerosis development in APOE*3-Leiden miceLoss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic miceEndothelial and macrophage-specific deficiency of P38α MAPK does not affect the pathogenesis of atherosclerosis in ApoE-/- mice.Myeloid IκBα deficiency promotes atherogenesis by enhancing leukocyte recruitment to the plaquesToll-like receptor signaling: a potential link among rheumatoid arthritis, systemic lupus, and atherosclerosis.SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesisLDL receptor knock-out mice are a physiological model particularly vulnerable to study the onset of inflammation in non-alcoholic fatty liver disease.Anti-atherosclerotic function of Astragali Radix extract: downregulation of adhesion molecules in vitro and in vivoHematopoietic miR155 deficiency enhances atherosclerosis and decreases plaque stability in hyperlipidemic mice.Protective role of plant sterol and stanol esters in liver inflammation: insights from mice and humansTNFalpha induces ABCA1 through NF-kappaB in macrophages and in phagocytes ingesting apoptotic cells.Insulin resistance and atherosclerosis.Induction of regulatory T cells by high-dose gp96 suppresses murine liver immune hyperactivation.BMP7 activates brown adipose tissue and reduces diet-induced obesity only at subthermoneutrality.Escherichia coli prevents phagocytosis-induced death of macrophages via classical NF-kappaB signaling, a link to T-cell activationInhibition of macrophage nuclear factor-kappaB leads to a dominant anti-inflammatory phenotype that attenuates glomerular inflammation in vivo.The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor κ light-chain enhancer of activated B cells (NF-κB) in miceHelper T cells and atherosclerosis: the cytokine webReductive metabolism increases the proinflammatory activity of aldehyde phospholipidsInhibition of Thrombin With PPACK-Nanoparticles Restores Disrupted Endothelial Barriers and Attenuates Thrombotic Risk in Experimental AtherosclerosisThematic review series: the immune system and atherogenesis. Immune function in atherogenesis.
P2860
Q24568066-99FFE84E-10F9-4F2A-BEAE-C27156EBDBB9Q26777991-C80B7F66-7681-499A-9CF1-7C417C4F8B46Q26860162-9B648B63-51BA-41D4-88CC-20B8F931143DQ26865593-DA079084-F2D0-40B0-A305-14A1EC40E832Q28590307-8DEC77DD-DBF9-4344-BAD4-9F253071C09DQ28731544-1450DC45-9DC8-4B39-AB88-4EE25F0FBD1CQ29617765-2CDD957D-3CB2-498E-A5D6-D8464E809FDAQ30251861-405CB701-7551-4A60-B832-E1EFB80D3CBEQ30300194-D5484BD0-6F30-4826-96D9-235A0D663238Q30420744-C5A19537-1ECB-4F9B-9AA1-04B25E67C061Q30435620-515F9AB4-F653-4C83-B09F-D9E350267E8FQ30497499-FCCE9839-6786-48CA-A755-C194BEF79006Q31124912-BCFC446E-169C-4CED-9F81-C2E2C1402258Q33569809-A3C20821-D900-4BAB-85CE-8D0F3D461C7DQ33580752-D4173635-5E0B-48F5-A762-ACA78B75CFD8Q33652079-1E20C108-6E73-4E25-905A-8EA81AC397E1Q33656103-55E67661-C7C9-48AD-B531-5795ED45DFB5Q33732848-AFD2F17B-6230-496C-9366-B0193AB96D75Q33761114-A731EEDB-4511-4F8D-9C01-86DA137A248BQ33898304-3DE0B16D-7FA5-4450-9977-F86A7F8C922EQ33905765-2B62DD02-5D6F-4070-8C41-9D63C095C5CDQ33939763-38107255-C8BE-43E0-9ED6-7B7C5CD1AA73Q33981521-CAC7F7A0-8216-4A8C-9A1C-B9D5A2B993EAQ34015433-7D568C31-DD59-415B-9E33-CBE31B1AB9DDQ34123761-C49020E8-2F01-4C54-A54C-ADD2C6C29ADBQ34147643-21700618-85C7-4308-903B-4295E2668122Q34247826-C4C0B201-00E1-40C3-88C2-75705A8015F2Q34256848-C218B938-10E6-49BB-A0B6-BDAE90264309Q34428267-B6D27D79-0858-4865-A1F3-E983CB2D555CQ34480157-B92DF1FE-D207-49FE-ADF7-AA0FD78A58C5Q34698887-E6DFDE07-2C4E-4CDB-AD32-B916C7B797E2Q34852383-239EE12C-8006-492F-B712-6DCA630EFE3AQ34997193-73D286D8-528C-4BB7-BC3F-0A3A980A2002Q35073831-6EB306F1-20A5-4987-970E-B96854AF9E41Q35084876-2565F28D-D710-4AFB-89DF-DBD2E9DD4A66Q35249092-D998DBEF-06CE-455D-BEB4-2902DA7B32C2Q35523321-156435DA-59E4-49C6-80D0-996092EA43FEQ35561973-33EA8F34-548D-4647-B705-5E7B9DA3A906Q35894640-FCC4C099-3E6D-4976-87A1-88BB268C9DF7Q35952305-FFAB2D95-06BD-4C76-BF26-18B7667A6C27
P2860
Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Inhibition of NF-kappaB activa ...... n LDL receptor-deficient mice.
@en
Inhibition of NF-kappaB activa ...... n LDL receptor-deficient mice.
@nl
type
label
Inhibition of NF-kappaB activa ...... n LDL receptor-deficient mice.
@en
Inhibition of NF-kappaB activa ...... n LDL receptor-deficient mice.
@nl
prefLabel
Inhibition of NF-kappaB activa ...... n LDL receptor-deficient mice.
@en
Inhibition of NF-kappaB activa ...... n LDL receptor-deficient mice.
@nl
P2093
P2860
P50
P921
P356
P1476
Inhibition of NF-kappaB activa ...... in LDL receptor-deficient mice
@en
P2093
Edwin Kanters
Georg Kraal
Iris Partouns-Hendriks
Marion J J Gijbels
Mark M Kockx
Marten H Hofker
Monique N Vergouwe
P2860
P304
P356
10.1172/JCI200318580
P407
P577
2003-10-01T00:00:00Z